2015-2019 Ph.D. of Zhejiang University, Zhejiang Province, China. Major: Oncology  

2017-2018 Harvard medical school/ Beth Israel Deaconess Medical Center Joint-Ph.D  sponsored by the China Scholarship Council  

2012-2015 Master of Clinical Medicine in Xiamen University, Fujian Province, China.  Major: Endocrinology and Metabolism  

2007-2012 Bachelor of Clinical Medicine in XiangYa School of Medicine , Central  South University, Hunan Province, China. Major: Clinical Medicine

2021-present The First Affiliated Hospital,College of Medicine, Zhejiang University  Attending Physician  

2019-2021 The First Affiliated Hospital,College of Medicine, Zhejiang University  Resident Physician

Mechanisms of carcinogenesis and novel therapeutic approaches for lung cancer and  hepatobiliary malignancies

2015-present Practice and participate research projects in Translational Medicine  Research Institute of Zhejiang University. Focus on checkpoint regulation by ubiquitin proteasome system. 

2013-2015 Practice and participate research projects(mainly about diabetic retinopathy) in Xiamen Endocrinology and Metabolic Disease Clinical Centre. Participate in the  application of National Natural Science Funds of China. Regulation mechanism of  Notch3 in Pericyte Apoptosis in Diabetic Retinopathy.( Grant No. 81400419)  Fundings The mechanism and biological significance of PML degradation by CK2/ SCFβ-TrCP  pathway in human Lung Adenocarcinoma; (Grant No. 82302895) Funding  Agency :National Natural Science Foundation (NNSF) of China Jan 1, 2024 - Dec 31,  2026 Role: Principal Investigator  Professional Memberships None